Salicornia, which is colloquially known as ‘sea asparagus,’ is rapidly emerging as a transformative solution for future food ...

Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management will present at the ...

Pasithea Therapeutics Corp. ( KTTA) Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 4:00 PM EST ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

The issued patent provides intellectual property protection for ERAS-4001 and related compositions until at least 2043 Expands Erasca’s diversified IP portfolio for RAS-driven cancers Initial Phase 1 ...

When 200 natural accessions of the model plant Arabidopsis thaliana grown in a nitrate-enriched medium were compared, one observation stood out: some accessions formed significantly longer lateral ...

By Hugo Francisco de Souza New research suggests that zinc does far more than support immunity, revealing intricate molecular switches that may influence how the heart responds to inflammatory injury.

The issued patent provides intellectual property protection for ERAS-4001 and related compositions until at least 2043 Expands Erasca's diversified IP portfolio for RAS-driven cancers Initial Phase 1 ...

Format: Company Presentation and 1x1 Investor Meetings Date/Time: Thursday, February 26, 2026, at 10:00 am ET The presentation will be webcast live and archived in the Investor Relations section of ...

According to a new CIBC poll, most Canadians plan to retire at 61 and are staying the course in their long-term financial strategies, with three quarters (76 per cent) reporting that their approach to ...

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, ...

A new human study has uncovered how the body naturally turns off inflammation. Researchers found that fat-derived molecules called epoxy-oxylipins rein in immune cells that can otherwise drive chronic ...